{"id":"https://openalex.org/W2116495306","doi":null,"title":"Effect of cyclooxygenase and nitric oxide synthase inhibitors on vincristine induced hyperalgesia in rats.","display_name":"Effect of cyclooxygenase and nitric oxide synthase inhibitors on vincristine induced hyperalgesia in rats.","publication_year":2008,"publication_date":"2008-09-01","ids":{"openalex":"https://openalex.org/W2116495306","mag":"2116495306","pmid":"https://pubmed.ncbi.nlm.nih.gov/19066421"},"language":"en","primary_location":{"id":"pmid:19066421","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19066421","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological reports : PR","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054226470","display_name":"Magdalena Bujalska\u2010Zadro\u017cny","orcid":"https://orcid.org/0000-0002-4270-6373","observed_orcids":["https://orcid.org/0000-0002-4270-6373"]},"institutions":[{"id":"https://openalex.org/I268303160","display_name":"Medical University of Warsaw","ror":"https://ror.org/04p2y4s44","country_code":"PL","type":"education","lineage":["https://openalex.org/I268303160"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Magdalena Bujalska","raw_affiliation_strings":["Department of Pharmacodynamics, Medical University of Warsaw, Krakowskie Przedmie\u015bcie 26/28, PL 00-927 Warszawa 64, P.O. Box 3, Poland. mbujalska@gmail.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacodynamics, Medical University of Warsaw, Krakowskie Przedmie\u015bcie 26/28, PL 00-927 Warszawa 64, P.O. Box 3, Poland. mbujalska@gmail.com","institution_ids":["https://openalex.org/I268303160"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006308075","display_name":"Stanis\u0142aw Witold Gumu\u0142ka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stanis\u0142aw W Gumu\u0142ka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.3506,"has_fulltext":false,"cited_by_count":24,"citation_normalized_percentile":{"value":0.77534415,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"60","issue":"5","first_page":"735","last_page":"41"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vincristine","display_name":"vincristine","score":0.8320000171661377},{"id":"https://openalex.org/keywords/cyclooxygenase-inhibitors","display_name":"cyclooxygenase inhibitors","score":0.9729999899864197},{"id":"https://openalex.org/keywords/nitric-oxide-synthase-inhibitors","display_name":"nitric oxide synthase inhibitors","score":0.9869999885559082},{"id":"https://openalex.org/keywords/indomethacin","display_name":"indomethacin","score":0.9319999814033508},{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ng-nitro-l-arginine","display_name":"L-NNA","score":0.9380000233650208},{"id":"https://openalex.org/keywords/l-nil","display_name":"L-NIL","score":0.8629999756813049},{"id":"https://openalex.org/keywords/7-nitroindazole","display_name":"7-nitroindazole","score":0.9980000257492065},{"id":"https://openalex.org/keywords/inducible-nitric-oxide-synthase","display_name":"inducible nitric oxide synthase","score":0.902999997138977},{"id":"https://openalex.org/keywords/neuronal-nitric-oxide-synthase","display_name":"neuronal nitric oxide synthase","score":0.9900000095367432},{"id":"https://openalex.org/keywords/cox-1","display_name":"cyclooxygenase-1","score":0.8610000014305115},{"id":"https://openalex.org/keywords/cyclooxygenase-2","display_name":"cyclooxygenase-2","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pain-transmission","display_name":"pain transmission","score":0.6209999918937683},{"id":"https://openalex.org/keywords/neuropathic-pain","display_name":"neuropathic pain","score":0.6389999985694885}],"concepts":[{"id":"https://openalex.org/C2779245659","wikidata":"https://www.wikidata.org/wiki/Q1633866","display_name":"Hyperalgesia","level":4,"score":0.8693636655807495},{"id":"https://openalex.org/C2777622882","wikidata":"https://www.wikidata.org/wiki/Q417619","display_name":"Nitric oxide synthase","level":3,"score":0.8391743898391724},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7339115738868713},{"id":"https://openalex.org/C2776467144","wikidata":"https://www.wikidata.org/wiki/Q408801","display_name":"Celecoxib","level":2,"score":0.7177539467811584},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6660556793212891},{"id":"https://openalex.org/C2779689624","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Cyclooxygenase","level":3,"score":0.6486034989356995},{"id":"https://openalex.org/C519581460","wikidata":"https://www.wikidata.org/wiki/Q207843","display_name":"Nitric oxide","level":2,"score":0.6224462985992432},{"id":"https://openalex.org/C2776980637","wikidata":"https://www.wikidata.org/wiki/Q427492","display_name":"Enzyme inhibitor","level":3,"score":0.49072229862213135},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.32061293721199036},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.23872989416122437},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1676042675971985},{"id":"https://openalex.org/C15490471","wikidata":"https://www.wikidata.org/wiki/Q2734305","display_name":"Nociception","level":3,"score":0.1219046413898468},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.09576684236526489},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068579","descriptor_name":"Celecoxib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000465","descriptor_name":"Algorithms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006930","descriptor_name":"Hyperalgesia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D006930","descriptor_name":"Hyperalgesia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D006930","descriptor_name":"Hyperalgesia","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D007213","descriptor_name":"Indomethacin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010147","descriptor_name":"Pain Measurement","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010147","descriptor_name":"Pain Measurement","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D010523","descriptor_name":"Peripheral Nervous System Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D010523","descriptor_name":"Peripheral Nervous System Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D010812","descriptor_name":"Physical Stimulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017288","descriptor_name":"Pain Threshold","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019001","descriptor_name":"Nitric Oxide Synthase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D019335","descriptor_name":"Nitroarginine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D052247","descriptor_name":"Nitric Oxide Synthase Type II","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D052248","descriptor_name":"Nitric Oxide Synthase Type I","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:19066421","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19066421","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological reports : PR","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W45469515","https://openalex.org/W1801320709","https://openalex.org/W1976798000","https://openalex.org/W1976949420","https://openalex.org/W1979597071","https://openalex.org/W1987139868","https://openalex.org/W1990267117","https://openalex.org/W1993321734","https://openalex.org/W1998899274","https://openalex.org/W2004637463","https://openalex.org/W2017610938","https://openalex.org/W2029396512","https://openalex.org/W2033189033","https://openalex.org/W2038064303","https://openalex.org/W2040010122","https://openalex.org/W2041488205","https://openalex.org/W2045886062","https://openalex.org/W2052716657","https://openalex.org/W2053597641","https://openalex.org/W2055297480","https://openalex.org/W2067212451","https://openalex.org/W2068992374","https://openalex.org/W2077985374","https://openalex.org/W2078041000","https://openalex.org/W2081369872","https://openalex.org/W2102729306","https://openalex.org/W2109541288","https://openalex.org/W2111414199","https://openalex.org/W2111584145","https://openalex.org/W2135411584","https://openalex.org/W2148733966","https://openalex.org/W2165416312","https://openalex.org/W2256167805"],"related_works":["https://openalex.org/W1979597071","https://openalex.org/W2077985374","https://openalex.org/W2414990135","https://openalex.org/W2157898480","https://openalex.org/W2065451295","https://openalex.org/W2054410657","https://openalex.org/W2124353813","https://openalex.org/W1982133780","https://openalex.org/W2078326734","https://openalex.org/W2040045598"],"abstract_inverted_index":{"The":[0,95],"purpose":[1],"of":[2,10,23,38,89,97,102,115],"this":[3,98],"study":[4,99],"was":[5],"to":[6,92],"investigate":[7],"the":[8,21,46,87,113],"effect":[9],"cyclooxygenase":[11],"(COX)":[12],"inhibitors":[13,19,37,44,85],"and":[14,29,40,51,76,104,110],"nitric":[15],"oxide":[16],"synthase":[17,72],"(NOS)":[18],"on":[20,57],"development":[22,88],"vincristine":[24],"(VIN)-induced":[25],"hyperalgesia.":[26,120],"Indomethacin":[27],"(IND)":[28],"celecoxib":[30],"(CEX)":[31],"were":[32],"used":[33],"as":[34,60,62,106,108],"relatively":[35,68],"selective":[36],"COX-1":[39,103],"COX-2,":[41],"respectively.":[42],"NOS":[43,84],"included":[45],"nonspecific":[47],"inhibitor":[48],"NG-nitro-Larginine":[49],"(L-NOArg)":[50],"L-N6-(1-iminoethyl)lysine":[52],"(L-NIL),":[53],"which":[54,65],"preferentially":[55],"acts":[56],"inducible":[58],"NOS,":[59],"well":[61,107],"7-nitroindazole":[63],"(7-NI),":[64],"is":[66],"a":[67],"specific":[69],"neuronal":[70],"NO":[71],"inhibitor.":[73],"Both":[74],"IND":[75],"CEX":[77],"markedly":[78],"suppressed":[79],"hyperalgesia,":[80],"whereas":[81],"all":[82],"three":[83],"prevented":[86],"hyperalgesia":[90],"due":[91],"VIN":[93],"administration.":[94],"results":[96],"suggest":[100],"participation":[101],"COX-2":[105],"iNOS":[109],"nNOS":[111],"in":[112,118],"transmission":[114],"pain":[116],"stimuli":[117],"VIN-induced":[119]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}